BRIAN SMITH: Open Payments
NPI 1992749873 · VERSAILLES, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 48 payments from 18 companies in 2025. Trend: 2023 $1,677 · 2024 $1,879 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $219 |
| PFIZER INC. | 3 | $62 |
| Indivior Inc. | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| EMD Serono, Inc. | 2 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Lundbeck LLC | 1 | $25 |
| Amgen Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: VRAYLAR, QULIPTA, SUBLOCADE, XIFAXAN, GLASSIA, Bylvay, REXULTI, NURTEC ODT.
Industry payments across KY — which companies pay providers there.
